Surgery

Osteoporosis, not just a woman's disease

Each year nearly two million Americans suffer osteoporosis-related fractures, and as the population ages that number is expected to increase dramatically, placing a major burden on the health care system. While osteoporosis ...

Medical research

Revealing a novel mode of action for an osteoporosis drug

(Medical Xpress)—Raloxifene is a U.S. Food and Drug Administration (FDA)-approved treatment for decreasing fracture risk in osteoporosis. While raloxifene is as effective at reducing fracture risk as other current treatments, ...

page 12 from 19